83 related articles for article (PubMed ID: 5761064)
21. The design and analysis of half-life and recovery studies for factor VIII and factor IX. Factor VIII/Factor IX Scientific and Standardization Committee of the International Society for Thrombosis and Haemostasis.
Morfini M; Lee M; Messori A
Thromb Haemost; 1991 Sep; 66(3):384-6. PubMed ID: 1746011
[No Abstract] [Full Text] [Related]
22. Collaborative study on assays of activated FIX (FIXa). On behalf of the factor VIII and factor IX subcommittee of the ISTH. International Society on Thrombosis and Haemostasis.
Gray E; Walker D; Heath A; Barrowcliffe TW
Thromb Haemost; 1996 Dec; 76(6):1114-7. PubMed ID: 8972040
[TBL] [Abstract][Full Text] [Related]
23. Immune tolerance in hemophilia-principal results from the International Registry. Report of the factor VIII and IX Subcommittee.
Mariani G; Ghirardini A; Bellocco R
Thromb Haemost; 1994 Jul; 72(1):155-8. PubMed ID: 7974364
[TBL] [Abstract][Full Text] [Related]
24. Revision of the protocol recommended for studies of safety from hepatitis of clotting factor concentrates. International Society for Thrombosis and Hemostasis.
Mannucci PM; Colombo M
Thromb Haemost; 1989 Jun; 61(3):532-4. PubMed ID: 2508261
[No Abstract] [Full Text] [Related]
25. Standardization of factor IX: standards for "purified" factor IX concentrates.
Lamb MA; Fricke WA; Rastogi SC
Thromb Haemost; 1991 Nov; 66(5):548-51. PubMed ID: 1803618
[TBL] [Abstract][Full Text] [Related]
26. In vivo recovery of factor VIII following transfusion: a survey of recent data and publications to assess the influence of standards used for potency assignment. On behalf of the Subcommittee on Factor VIII and IX of the Scientific and Standardization Committee of the ISTH.
Prowse CV
Thromb Haemost; 1995 Oct; 74(4):1191-6. PubMed ID: 8560434
[TBL] [Abstract][Full Text] [Related]
27. Report of the Subcommittee on Factor VIII Activities.
Nilsson IM; Meyer D; Hoyer LW; Ingram GI; Rizza CR
Thromb Haemost; 1980 Jun; 43(2):163-6. PubMed ID: 6779395
[No Abstract] [Full Text] [Related]
28. International and national standards for factor VIII.
Barrowcliffe TW
Scand J Haematol Suppl; 1984; 40():131-8. PubMed ID: 6433443
[No Abstract] [Full Text] [Related]
29. [Comparison of factor VIII:C and factor IX sensitivity of different commercial APTT reagents for canine plasma].
Mischke R
Berl Munch Tierarztl Wochenschr; 1999; 112(10-11):394-9. PubMed ID: 10598358
[TBL] [Abstract][Full Text] [Related]
30. Inhibitor antibodies to factor VIII and factor IX: management.
Lusher JM
Semin Thromb Hemost; 2000; 26(2):179-88. PubMed ID: 10919411
[TBL] [Abstract][Full Text] [Related]
31. [Factor VIII preparations of varying purity-examination of physico-chemical parameters (author's transl)].
Vukovich T; Koller E; Doleschel W; Mayr WR
Wien Klin Wochenschr; 1980; 92(11):385-91. PubMed ID: 6775418
[TBL] [Abstract][Full Text] [Related]
32. Factor VIII, factor IX and fibrinogen content in cryoprecipitate, fresh plasma and cryoprecipitate-removed plasma.
Bejrachandra S; Chandanayingyong D; Visudhiphan S; Tumliang S; Kaewkamol K; Siribunrit U
Southeast Asian J Trop Med Public Health; 1993; 24 Suppl 1():162-4. PubMed ID: 7886562
[TBL] [Abstract][Full Text] [Related]
33. [Measurements of the activity of the coagulation factors VIII:C, IX,XI, and XII in cats].
Mischke R; Deniz A; Nolte I
Zentralbl Veterinarmed A; 1995 Oct; 42(8):513-20. PubMed ID: 8592897
[TBL] [Abstract][Full Text] [Related]
34. [Substitution therapy with factor 8 and factor IX preparations].
Landbeck G
Hamatol Bluttransfus; 1968; 5():29-42. PubMed ID: 5729465
[No Abstract] [Full Text] [Related]
35. Factor VIII and factor IX Sub-Committee. Recommendations for the assay of high-purity factor VIII concentrates.
Barrowcliffe TW
Thromb Haemost; 1993 Nov; 70(5):876-7. PubMed ID: 8128450
[No Abstract] [Full Text] [Related]
36. Effects of thrombin treatment of preparations of factor VIII and the Ca2+-dissociated small active fragment.
Cooper HA; Reisner FF; Hall M; Wagner RH
J Clin Invest; 1975 Sep; 56(3):751-60. PubMed ID: 1080490
[TBL] [Abstract][Full Text] [Related]
37. Absence of correlation between X chromosome inactivation pattern and plasma concentration of factor VIII and factor IX in carriers of haemophilia A and B.
Orstavik KH; Scheibel E; Ingerslev J; Schwartz M
Thromb Haemost; 2000 Mar; 83(3):433-7. PubMed ID: 10744150
[TBL] [Abstract][Full Text] [Related]
38. Recommendations: Diagnosis of AIDS used by the Centers for Disease Control.
Eur J Cancer Clin Oncol; 1984 Feb; 20(2):169-73. PubMed ID: 6423387
[No Abstract] [Full Text] [Related]
39. Relation of factor VIII and IX inhibitors with ABO blood groups in 150 patients with haemophilia A and B.
Torghabeh HM; Pourfathollah A; Shooshtari MM; Yazdi ZR
Iran J Allergy Asthma Immunol; 2006 Mar; 5(1):33-4. PubMed ID: 17242502
[TBL] [Abstract][Full Text] [Related]
40. Definitions in hemophilia. Recommendation of the scientific subcommittee on factor VIII and factor IX of the scientific and standardization committee of the International Society on Thrombosis and Haemostasis.
White GC; Rosendaal F; Aledort LM; Lusher JM; Rothschild C; Ingerslev J;
Thromb Haemost; 2001 Mar; 85(3):560. PubMed ID: 11307831
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
